The need for molecular diagnostic assays is growing at an unprecedented rate. With new biomarkers being discovered and standard catalog reagents becoming more accessible, diagnostic developers and manufacturers can create molecular tests faster than ever before.
Diagnostic assay developers typically design assays using standard catalog reagents available in wet chemistry format because they are widely available, easy to source, and simple to combine with other components in a laboratory setting for optimization.
Although wet chemistry is the traditionally used format, some reagents are not stable at ambient temperatures long-term and therefore need cold chain shipping and handling, adding risk and cost to logistics associated with sourcing the reagents for the test.
This white paper from Fortis Life Sciences highlights lyophilization’s role in addressing some of these common challenges.